cisplatin
CDR0000667764
Phase 2 small_molecule completed
Quick answer
cisplatin for Bladder Cancer is a Phase 2 program (small_molecule) at Cardiff Oncology with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Cardiff Oncology
- Indication
- Bladder Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed